Showing results (381-390 of 1,645) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|April 16, 2026
Missing Data Handling in the Application of Matching-Adjusted Indirect ComparisonYixin Fang, Moming Li, Jeff Lai, et al.Therapeutic Innovation & Regulatory Science|June 3, 2026
Stability and Efficacy of Medicines Beyond Their Expiration Dates: A Systematic ReviewGoodluck G Nyondo, Martine A Manguzu, Eliangiringa A Kaale, et al.Therapeutic Innovation & Regulatory Science|May 28, 2026
Pharmacoeconomic Evaluation of Netupitant Palonosetron for Chemotherapy-Induced Nausea and Vomiting: Evidence from Economic AnalysesMeiyan Zhang, Fan Zhang, Chen Tian, et al.Therapeutic Innovation & Regulatory Science|May 28, 2026
Feasibility of a Monthly Morphine Milligram Equivalent Metric for Opioid Surveillance Using the National Claims Database of Japan: A Repeated Cross-Sectional Study in a Low-Consumption SettingKeiko Yamada, Masako IsekiTherapeutic Innovation & Regulatory Science|May 28, 2026
Simulation-Calibrated Control of Type I Error Rate in One-Trial Approach with Dose Optimization in Oncology Drug DevelopmentZhao YangTherapeutic Innovation & Regulatory Science|April 24, 2026
Web-based Dossier Management System (DMS) and Emerging Technologies to Facilitate Faster Registration and Access to Human Drugs: NAFDAC's ExperienceMojisola Christianah Adeyeye, Uche Sonny-Afoekelu, Edosa Ogbeide, et al.Therapeutic Innovation & Regulatory Science|May 23, 2026
Arbitrated Indirect Treatment ComparisonsYixin Fang, Weili HeTherapeutic Innovation & Regulatory Science|January 24, 2024
Incorporating Prior Data in Quantitative Benefit-Risk Assessments: Case Study of a Bayesian MethodSai Dharmarajan, Zhong Yuan, Yeh-Fong Chen, et al.Therapeutic Innovation & Regulatory Science|May 13, 2026
Accelerating Global Access for Indication Extension Through Regulatory Reliance Pilot: The First Indication Extension Pilot in OncologyAnna Litsiou, Melanie Jane Snow, Emma Morgan, et al.Therapeutic Innovation & Regulatory Science|May 4, 2026
Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities-A TransCelerate PerspectiveJames Whitehead, Rajesh Ghosh, Anna Monaco, et al.Pageof 165